Plasma cell leukemia 3 months after autologous blood cell transplantation for multiple myeloma

被引：2

作者：

Koskela, K

Pelliniemi, TT

Lakkala, T

Remes, K

机构：

[1] Univ Turku, Cent Hosp, Dept Med, FIN-20520 Turku, Finland

[2] Univ Turku, Cent Hosp, Dept Hematol Lab, FIN-20520 Turku, Finland

[3] Univ Turku, Cent Hosp, Dept Med Genet, FIN-20520 Turku, Finland

[4] MediCity Res Ctr, Turku, Finland

来源：

BONE MARROW TRANSPLANTATION | 1998年 / 21卷 / 03期

关键词：

multiple myeloma; intensive therapy; autologous stem cell transplantation; autologous blood cell transplantation; karyotypic analysis;

D O I：

10.1038/sj.bmt.1701080

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

We describe a patient with multiple myeloma who was treated with intensive therapy and autologous blood cell transplantation as her first-line treatment, The disease relapsed 3 months after the transplant as plasma cell leukemia and the patient succumbed in 4 weeks, We suggest that an aggressive plasma cell clone may be selected during the course of intensive treatment, Complex karyotypic findings are also presented.

引用

页码：305 / 307

页数：3

共 10 条

[1] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Stoppa, AM ;

Sotto, JJ ;

Fuzibet, JG ;

Rossi, JF ;

Casassus, P ;

Maisonneuve, H ;

Facon, T ;

Ifrah, N ;

Payen, C ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97

[2] PROGNOSTIC FACTORS IN AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MULTIPLE-MYELOMA - AN EBMT REGISTRY STUDY [J].

BJORKSTRAND, B ;

GOLDSTONE, AH ;

LJUNGMAN, P ;

BRANDT, L ;

BRUNET, S ;

CARLSON, K ;

PRENTICE, HG ;

CAVO, M ;

SAMSON, D ;

DELAURENZI, A ;

VERDONCK, LF ;

PROCTOR, S ;

FERRANT, A ;

SIERRA, J ;

AUZANNEAU, G ;

TROUSSARD, X ;

GRAVETT, P ;

REMES, K ;

GAHRTON, G .

LEUKEMIA & LYMPHOMA, 1994, 15 (3-4) :265-272

[3] Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation [J].

Bjorkstrand, B ;

Ljungman, P ;

Svensson, H ;

Hermans, J ;

Alegre, A ;

Apperley, J ;

Blade, J ;

Carlson, K ;

Cavo, M ;

Ferrant, A ;

Goldstone, AH ;

deLaurenzi, A ;

Majolino, I ;

Marcus, R ;

Prentice, HG ;

Remes, K ;

Samson, D ;

Sureda, A ;

Verdonck, LF ;

Volin, L ;

Gahrton, G .

BLOOD, 1996, 88 (12) :4711-4718

[4] Allogeneic bone marrow transplantation in multiple myeloma [J].

Gahrton, G .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) :251-254

[5]

KLEIN B, 1995, SEMIN HEMATOL, V32, P4

[6]

KOSMO MA, 1987, SEMIN HEMATOL, V24, P202

[7]

MARIETTE X, 1994, BONE MARROW TRANSPL, V14, P47

[8] TRANSPLANTATION OF CD34(+) PERIPHERAL-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA [J].

SCHILLER, G ;

VESCIO, R ;

FREYTES, C ;

SPITZER, G ;

SAHEBI, F ;

LEE, M ;

WU, CH ;

CAO, J ;

LEE, JC ;

HONG, CH ;

LICHTENSTEIN, A ;

LILL, M ;

HALL, J ;

BERENSON, R ;

BERENSON, J .

BLOOD, 1995, 86 (01) :390-397

[9]

TRICOT G, 1995, BONE MARROW TRANSPL, V16, P7

[10]

Zandecki M, 1996, BRIT J HAEMATOL, V94, P217

← 1 →